Healthscope Divests Asia Pacific Healthcare Group

Healthscope Divests Asia Pacific Healthcare Group

In an effort to refocus its business plan, Healthscope is selling Asia Pacific Healthcare Group (APHG), its New Zealand pathology business. With 25 laboratories, over 2,000 staff, and 150 collection centers throughout the country, APHG performed over 6.7 million pathology patient episodes across New Zealand in 2019. The group has also been heavily involved in providing testing as part of New Zealand’s response to COVID-19. Healthscope is the second-largest private hospital operator in Australia The buyers are the New Zealand Superannuation Fund (NZ Super Fund), which invests money on behalf of the New Zealand government to help pay for the increased cost of universal pension entitlements... Read More »
U.S. Hospital REIT Deals Roar Back in 2019

U.S. Hospital REIT Deals Roar Back in 2019

REIT deals are back in the Hospital sector, after a two-year lull. Through mid-July, six transactions targeting U.S. hospitals were announced by real estate investment trusts (REITs), a total that equals the annual REIT deal volume of 2013, 2015 and 2016. Three of this year’s U.S. deals were announced in July 2019. Medical Properties Trust (NYSE: MPW) made a splash, announcing a combined $1.75 billion invesment in 24 hospital facilities through three separate transactions. The largest of the three, at $1.55 billion, was for 14 acute care hospitals and two behavioral health hospitals (2,383 beds) owned by for-profit Prospect Medical Holdings in California, Connecticut and... Read More »
Healthcare Dollar Volume Exploded in January

Healthcare Dollar Volume Exploded in January

Dollar volume for healthcare deals announced in January was ridiculous, topping $90 billion. We don’t see figures like that in most quarters. The outsized total results from a single deal, of course. Bristol-Myers Squibb’s (NYSE: BMY) $74 billion acquisition of Celgene Corp. (NASDAQ: CELG) made up 81% of the month’s total. Suffice it to say we won’t see many (or any) more months like this. The Hospital sector made a strong contribution, nearly $6 billion. The biggest deal wasn’t a domestic one, however. Australia’s second largest private hospital network, Healthscope Ltd. (ASX: HSO), was acquired by Brookfield Business Partners LP (NYSE: BBU) for approximately $4.1 billion. Two REITs are... Read More »
Healthscope Divests Asia Pacific Healthcare Group

Healthscope Changes Hands Again

Healthscope Ltd. (ASX: HSO), Australia’s second largest private hospital chain, is being sold once again, this time for $4.14 billion, or 1.8x revenue. The Melbourne, Victoria-based company owns 43 hospitals across all states in Australia and is the largest pathology services provider in New Zealand, with 24 laboratories. Three buyers are involved, two of them real estate investment trusts (REITs). First, Brookfield Business Partners LP (NYSE: BBU), a subsidiary of Brookfield Asset Management Inc. (NYSE: BAM), will acquire 100% of Healthscope’s shares, priced at $1.81 (AU$2.50) per share. That returns approximately $1.0 billion in equity. The remainder will be paid with $1.4... Read More »